IDH1 and central nervous system cancer: Notably, in our study, there was a significantly greater proportion of patients with IDH-wildtype gliomas with a histological grade of 2 or 3 (molecular glioblastoma) (15.6% vs. 3.8%, P < 0.001) among those with GC than among those without GC.